Retinopathy of Prematurity (ROP)

Also known as: Premature Retinopathy / ROP - Retinopathy of Prematurity / Retinopathy of Prematurity / Retrolental fibroplasia / Retinopathy of prematurity, unspecified / Retinopathy of prematurity (disorder)

Drug	Drug Name	Drug Description
DB08885	Aflibercept	A vascular endothelial growth factor (VEGF) inhibitor used to treat Neovascular (Wet) Age-Related Macular Degeneration (AMD), various types of macular edema and diabetic retinopathy, and metastatic colorectal cancer
DB01270	Ranibizumab	A recombinant humanized monoclonal antibody and VEGF-A antagonist used for the management of macular edema after retinal vein occlusion, age-related macular degeneration (wet), and diabetic macular edema.

Drug	Drug Name	Target	Type
DB08885	Aflibercept	Vascular endothelial growth factor A, long form	target
DB08885	Aflibercept	Placenta growth factor	target
DB08885	Aflibercept	Vascular endothelial growth factor B	target
DB01270	Ranibizumab	Vascular endothelial growth factor A, long form	target

Drug	Drug Name	Phase	Status	Count
DB00316	Acetaminophen	Not Available	Completed	1
DB00316	Acetaminophen	Not Available	Unknown Status	1
DB08885	Aflibercept	Not Available	Recruiting	2
DB00112	Bevacizumab	Not Available	Completed	1
DB00112	Bevacizumab	Not Available	No Longer Available	1
DB00979	Cyclopentolate	Not Available	Completed	1
DB00016	Erythropoietin	Not Available	Unknown Status	1
DB01050	Ibuprofen	Not Available	Completed	1
DB01592	Iron	Not Available	Recruiting	1
DB01592	Iron	Not Available	Unknown Status	1
DB00388	Phenylephrine	Not Available	Completed	1
DB00807	Proparacaine	Not Available	Terminated	1
DB00571	Propranolol	Not Available	Unknown Status	1
DB01270	Ranibizumab	Not Available	Completed	3
DB02772	Sucrose	Not Available	Completed	1
DB00755	Tretinoin	Not Available	Completed	1
DB00809	Tropicamide	Not Available	Completed	1
DB00162	Vitamin A	Not Available	Completed	1
DB00163	Vitamin E	Not Available	Completed	1
DB17926	Autologous cord blood	1	Unknown Status	1
DB00112	Bevacizumab	1	Completed	1
DB00112	Bevacizumab	1	Terminated	1
DB01234	Dexamethasone	1	Recruiting	1
DB00016	Erythropoietin	1 / 2	Unknown Status	1
DB00571	Propranolol	1 / 2	Completed	1
DB13165	Ripasudil	1 / 2	Completed	1
DB02772	Sucrose	1 / 2	Completed	1
DB00112	Bevacizumab	2	Recruiting	1
DB00112	Bevacizumab	2	Unknown Status	1
DB00112	Bevacizumab	2	Withdrawn	1
DB00201	Caffeine	2	Completed	1
DB09341	Dextrose, unspecified form	2	Completed	1
DB13961	Fish oil	2	Completed	1
DB01050	Ibuprofen	2	Completed	1
DB11196	Inositol	2	Completed	1
DB13178	Inositol	2	Completed	1
DB00465	Ketorolac	2	Completed	1
DB14751	Mecasermin rinfabate	2	Completed	2
DB14751	Mecasermin rinfabate	2	Recruiting	1
DB11133	Omega-3 fatty acids	2	Completed	1
DB00571	Propranolol	2	Completed	2
DB00571	Propranolol	2	Recruiting	1
DB00571	Propranolol	2	Unknown Status	1
DB01270	Ranibizumab	2	Completed	1
DB05897	rhIGFBP-3	2	Completed	2
DB08162	Fasudil	2 / 3	Unknown Status	1
DB00571	Propranolol	2 / 3	Completed	1
DB09145	Water	2 / 3	Unknown Status	1
DB08885	Aflibercept	3	Active Not Recruiting	1
DB08885	Aflibercept	3	Completed	2
DB00112	Bevacizumab	3	Completed	1
DB00112	Bevacizumab	3	Terminated	1
DB00633	Dexmedetomidine	3	Not Yet Recruiting	1
DB13961	Fish oil	3	Completed	1
DB08818	Hyaluronic acid	3	Completed	1
DB11196	Inositol	3	Terminated	1
DB13959	Medium-chain triglycerides	3	Completed	1
DB09567	Olive oil	3	Completed	1
DB00892	Oxybuprocaine	3	Completed	1
DB01270	Ranibizumab	3	Completed	3
DB09422	Soybean oil	3	Completed	1
DB00575	Clonidine	4	Recruiting	1
DB00979	Cyclopentolate	4	Completed	1
DB01075	Diphenhydramine	4	Terminated	1
DB00465	Ketorolac	4	Terminated	1
DB00388	Phenylephrine	4	Completed	3
DB00936	Salicylic acid	4	Recruiting	1
DB00809	Tropicamide	4	Completed	3
DB00162	Vitamin A	4	Completed	1
DB09145	Water	4	Completed	2
DB09145	Water	4	Recruiting	1
DB09322	Zinc sulfate	4	Unknown Status	1